Safety and Efficacy of Bexagliflozin as Monotherapy in Patients With Type 2 Diabetes

Summary

The purpose of this study is to investigate the effect of bexagliflozin in lowering hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes mellitus (T2DM).

Timeline

Start

2016-03

Primary completion

2017-04

Completion

2017-04

Drugs

Indications